Deutsche Bank
CARM

Deutsche Bank’s Carisma Therapeutics CARM Stock Holding History

Deutsche Bank’s Portfolio CARM Stock Details CARM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-12,267
Closed -$27.8K – 3579
2024
Q1 		$27.8K Hold
12,267
– – ﹤0.01% 3478
2023
Q4 		$35.9K Hold
12,267
– – ﹤0.01% 3451
2023
Q3 		$51.9K Buy
+12,267
New +$77.6K ﹤0.01% 3403
2022
Q2 		– Sell
-5,715
Closed -$69K – 4145
2022
Q1 		$69K Sell
5,715
-766
-12% -$10.7K ﹤0.01% 3722
2021
Q4 		$106K Sell
6,481
-37,236
-85% -$750K ﹤0.01% 3677
2021
Q3 		$693K Sell
43,717
-15,107
-26% -$725K ﹤0.01% 2844
2021
Q2 		$5.43M Buy
58,824
+9,803
+20% +$625K ﹤0.01% 1467
2021
Q1 		$2.55M Buy
49,021
+47,717
+3,659% +$2.25M ﹤0.01% 1990
2020
Q4 		$35K Hold
1,304
– – ﹤0.01% 4173
2020
Q3 		$37K Buy
+1,304
New +$26.1K ﹤0.01% 3991
2019
Q3 		– Sell
-35
Closed -$1K – 4909
2019
Q2 		$1K Buy
+35
New +$1.05K ﹤0.01% 5216
2018
Q4 		– Sell
-700
Closed -$30K – 5167
2018
Q3 		$30K Sell
700
-1,274
-65% -$49.6K ﹤0.01% 4832
2018
Q2 		$77K Buy
+1,974
New +$87K ﹤0.01% 4632
2017
Q3 		– Sell
-10
Closed – – 4881
2017
Q2 		$0 Sell
10
-25
-71% -$834 ﹤0.01% 4942
2017
Q1 		$1K Buy
+35
New +$1.46K ﹤0.01% 4811
2015
Q4 		– Sell
-661
Closed -$31K – 5272
2015
Q3 		$31K Buy
661
+623
+1,639% +$38.4K ﹤0.01% 4625
2015
Q2 		$2K Buy
+38
New +$5.36K ﹤0.01% 5229
2015
Q1 		– Hold
0
– – – 5165
2014
Q4 		– Sell
-2
Closed -$449 – 6155
2014
Q3 		$0 Sell
2
-58
-97% -$13.8K ﹤0.01% 5895
2014
Q2 		$15K Buy
60
+3
+5% +$742 ﹤0.01% 5395
2014
Q1 		$17K Buy
+57
New +$17.1K ﹤0.01% 4888

Other funds holding CARM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TOTUOP
Trustees of The University of Pennsylvania Philaldelphia, Pennsylvania $297M AUM
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Deutsche Bank's CARM Position: Q2 2024 in Review

Deutsche Bank sold out of Carisma Therapeutics (CARM) in Q2 2024, closing a stake of 12,267 shares — an estimated $27.8K sold.

Deutsche Bank first reported a position in CARM in Q1 2014 and held it in 20 quarters. The position peaked at $5.43M in Q2 2021. 53 funds tracked by Wall St. Rank hold CARM as of Q2 2024.

  • Deutsche Bank reported no remaining Carisma Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Deutsche Bank sold 12,267 Carisma Therapeutics shares in Q2 2024, an estimated $27.8K.
  • Deutsche Bank first reported a position in Carisma Therapeutics in Q1 2014 and held it in 20 quarters.
  • Deutsche Bank's Carisma Therapeutics position peaked at $5.43M in Q2 2021.
  • 53 funds tracked by Wall St. Rank held Carisma Therapeutics as of Q2 2024.

Based on Deutsche Bank's 13F filing for Q2 2024, filed 14 Aug 2024.